Janney Downgrades Champions Oncology (CSBR) to Neutral
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.95 --0%
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 6
Rating Summary:
4 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 6
Join SI Premium – FREE
Janney analyst Paul Knight downgraded Champions Oncology (NASDAQ: CSBR) from Buy to Neutral.
For an analyst ratings summary and ratings history on Champions Oncology click here. For more ratings news on Champions Oncology click here.
Shares of Champions Oncology closed at $7.06 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Downgrades Better Home & Finance Holding (BETR) to Neutral
- Deutsche Bank Downgrades Qifu Technology (3660:HK) (QFIN) to Hold
- Axis Capital Limited Downgrades Landmark Cars (LANDMARK:IN) to Add (2)
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
